Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Covalent attachment of functionalized cardiolipin on a biosensor gold surface allows repetitive measurements of anticardiolipin antibodies in serum.

Schlichtiger A, Baier C, Yin MX, Holmes AB, Maruyama M, Strasser R, Rant U, Thaler M, Luppa PB.

Anal Bioanal Chem. 2013 Jan;405(1):275-85. doi: 10.1007/s00216-012-6467-8. Epub 2012 Oct 23.

PMID:
23090649
2.

Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.

Metzger J, von Landenberg P, Kehrel M, Buhl A, Lackner KJ, Luppa PB.

Clin Chem. 2007 Jun;53(6):1137-43. Epub 2007 Apr 13.

3.
5.
6.

Development of a new parallelized, optical biosensor platform for label-free detection of autoimmunity-related antibodies.

Bleher O, Schindler A, Yin MX, Holmes AB, Luppa PB, Gauglitz G, Proll G.

Anal Bioanal Chem. 2014 May;406(14):3305-14. doi: 10.1007/s00216-013-7504-y. Epub 2013 Nov 27.

PMID:
24281326
7.

Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies.

Pierangeli SS, Harris EN, Davis SA, DeLorenzo G.

Br J Haematol. 1992 Nov;82(3):565-70.

PMID:
1486036
8.
9.

[Cardiolipin antibodies dependents on beta2-glycoprotein-1 in antiphospholipid syndrome].

Kuznetsova TV, Tishchenko VA, Kobylianskiń≠ AG, Pal'keeva ME, Novikov AA, Reshetniak TM, Kliukvina NG, Nasonov EL.

Ter Arkh. 1999;71(12):41-4. Russian.

PMID:
10647200
10.

Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.

Villalta D, Alessio MG, Tampoia M, Da Re A, Stella S, Da Re M, Tozzoli R, Bizzaro N.

Ann N Y Acad Sci. 2009 Sep;1173:21-7. doi: 10.1111/j.1749-6632.2009.04659.x.

PMID:
19758127
11.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
12.

Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.

Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G.

Clin Exp Immunol. 2005 Apr;140(1):173-80.

13.

Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.

Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE.

Clin Exp Immunol. 2015 May;180(2):218-26. doi: 10.1111/cei.12573.

14.

beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome.

Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GR.

Arthritis Rheum. 1994 Oct;37(10):1453-61.

PMID:
7945470
15.
16.

Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.

Vlachoyiannopoulos PG, Beigbeder G, Dueymes M, Youinou P, Hunt JE, Krilis SA, Moutsopoulos HM.

Autoimmunity. 1993;16(4):245-9.

PMID:
8025204
17.

Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against ő≤2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.

Andreoli L, Chighizola CB, Nalli C, Gerosa M, Borghi MO, Pregnolato F, Grossi C, Zanola A, Allegri F, Norman GL, Mahler M, Meroni PL, Tincani A.

Arthritis Rheumatol. 2015 May;67(8):2196-204. doi: 10.1002/art.39187.

18.

APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.

Int J Clin Exp Pathol. 2012;5(3):210-5. Epub 2012 Mar 25.

19.

Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies.

La Rosa L, Covini G, Galperin C, Catelli L, Del Papa N, Reina G, Morabito A, Balestrieri G, Tincani A, Gershwin ME, Meroni PL.

Clin Exp Immunol. 1998 Apr;112(1):144-51.

20.

Antiphospholipid syndrome: 30 years and our contribution.

Koike T.

Int J Rheum Dis. 2015 Feb;18(2):233-41. doi: 10.1111/1756-185X.12438. Epub 2014 Dec 19. Review.

PMID:
25524556

Supplemental Content

Support Center